News
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...
Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...
Moderna Covid vaccine approved for those 12-64 with risk factors Moderna expects mNEXSPIKE to be ready for 2025-2026 season ...
The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.
HHS has been following Kennedy's lead on vaccines, from limiting who can get Covid boosters to withdrawing funding for a ...
There is no “the” vaccine. There are at least two mRNA vaccines (Moderna and Pfizer) and a number of different non-mRNA ...
A new COVID variant has been reported in China, which could lead to another round of COVID booster shots in America.
Government advisers debate updating COVID-19 vaccines for next season amid confusion over new U.S. policy on booster shots.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results